» Articles » PMID: 31565033

MiR-221 Alleviates the Ox-LDL-Induced Macrophage Inflammatory Response Via the Inhibition of DNMT3b-Mediated NCoR Promoter Methylation

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2019 Oct 1
PMID 31565033
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis (AS) is a chronic inflammatory disease, and macrophages play a key role in all phases of AS. Recent studies have shown that miR-221 is a biomarker for AS and stroke; however, the role and mechanism of miR-221 in AS are unclear. Herein, we found that miR-221 and NCoR levels were decreased in ox-LDL-treated THP-1-derived macrophages. In contrast, DNMT3b, IL-6, and TNF- expression levels were increased under these conditions. Upregulation of miR-221 or NCoR could partially inhibit ox-LDL-induced IL-6 and TNF- expression. Further studies showed that DNMT3b was a target of miR-221. DNMT3b inhibition also suppressed IL-6 and TNF- expression and increased NCoR expression in the presence of ox-LDL. Moreover, DNMT3b was involved in ox-LDL-induced DNA methylation in the promoter region of NCoR. These findings suggest that miR-221 suppresses ox-LDL-induced inflammatory responses via suppressing DNMT3b-mediated DNA methylation in the promoter region of NCoR. These results provide a rationale for using intracellular miR-211 as a possible antiatherosclerotic target.

Citing Articles

MicroRNAs Regulate Function in Atherosclerosis and Clinical Implications.

Li Z, Zhao Y, Suguro S, Suguro R Oxid Med Cell Longev. 2023; 2023:2561509.

PMID: 37675243 PMC: 10480027. DOI: 10.1155/2023/2561509.


Smooth muscle liver kinase B1 inhibits foam cell formation and atherosclerosis via direct phosphorylation and activation of SIRT6.

Deng Q, Li H, Yue X, Guo C, Sun Y, Ma C Cell Death Dis. 2023; 14(8):542.

PMID: 37607939 PMC: 10444762. DOI: 10.1038/s41419-023-06054-x.


Myeloid DNA methyltransferase3b deficiency aggravates pulmonary fibrosis by enhancing profibrotic macrophage activation.

Qin W, Spek C, Scicluna B, van der Poll T, Duitman J Respir Res. 2022; 23(1):162.

PMID: 35725453 PMC: 9210707. DOI: 10.1186/s12931-022-02088-5.


Epigenetic regulation of inflammatory factors in adipose tissue.

Jung B, Kang S Biochim Biophys Acta Mol Cell Biol Lipids. 2021; 1866(11):159019.

PMID: 34332076 PMC: 8719460. DOI: 10.1016/j.bbalip.2021.159019.


DNA Methylation in Atherosclerosis: A New Perspective.

Zhang Y, Mei J, Li J, Zhang Y, Zhou Q, Xu F Evid Based Complement Alternat Med. 2021; 2021:6623657.

PMID: 34257689 PMC: 8249120. DOI: 10.1155/2021/6623657.


References
1.
Barish G, Yu R, Karunasiri M, Becerra D, Kim J, Tseng T . The Bcl6-SMRT/NCoR cistrome represses inflammation to attenuate atherosclerosis. Cell Metab. 2012; 15(4):554-62. PMC: 3367511. DOI: 10.1016/j.cmet.2012.02.012. View

2.
Momtazi-Borojeni A, Abdollahi E, Nikfar B, Chaichian S, Ekhlasi-Hundrieser M . Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy. Heart Fail Rev. 2019; 24(3):399-409. DOI: 10.1007/s10741-018-09764-z. View

3.
Wagner B, Norris J, Knotts T, Weigel N, McDonnell D . The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol Cell Biol. 1998; 18(3):1369-78. PMC: 108850. DOI: 10.1128/MCB.18.3.1369. View

4.
Moreno-Navarrete J, Ortega F, Bassols J, Ricart W, Fernandez-Real J . Decreased circulating lactoferrin in insulin resistance and altered glucose tolerance as a possible marker of neutrophil dysfunction in type 2 diabetes. J Clin Endocrinol Metab. 2009; 94(10):4036-44. DOI: 10.1210/jc.2009-0215. View

5.
Sarrazy V, Sore S, Viaud M, Rignol G, Westerterp M, Ceppo F . Maintenance of Macrophage Redox Status by ChREBP Limits Inflammation and Apoptosis and Protects against Advanced Atherosclerotic Lesion Formation. Cell Rep. 2015; 13(1):132-144. DOI: 10.1016/j.celrep.2015.08.068. View